BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34140204)

  • 1. Thoracic CT screening: using routinely detectable COPD information.
    Rizzo A; Mulshine JL
    Clin Imaging; 2021 Oct; 78():310-312. PubMed ID: 34140204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.
    Xia C; Rook M; Pelgrim GJ; Sidorenkov G; Wisselink HJ; van Bolhuis JN; van Ooijen PMA; Guo J; Oudkerk M; Groen H; van den Berge M; van der Harst P; Dijkstra H; Vonder M; Heuvelmans MA; Dorrius MD; De Deyn PP; de Bock GH; Dotinga A; Vliegenthart R
    Eur J Epidemiol; 2020 Jan; 35(1):75-86. PubMed ID: 31016436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
    Chung JH; Richards JC; Koelsch TL; MacMahon H; Lynch DA
    AJR Am J Roentgenol; 2018 Mar; 210(3):503-513. PubMed ID: 29231759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT.
    Tang LYW; Coxson HO; Lam S; Leipsic J; Tam RC; Sin DD
    Lancet Digit Health; 2020 May; 2(5):e259-e267. PubMed ID: 33328058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases.
    Mets OM; de Jong PA; Prokop M
    JAMA; 2012 Oct; 308(14):1433-4. PubMed ID: 23047354
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-Dose Computed Tomography Screening Proposal for the "Big-3 Diseases": Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease.
    Spinnato P
    Acad Radiol; 2021 Jan; 28(1):46-48. PubMed ID: 32807607
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.
    Heuvelmans MA; Vonder M; Rook M; Groen HJM; De Bock GH; Xie X; Ijzerman MJ; Vliegenthart R; Oudkerk M
    J Thorac Imaging; 2019 May; 34(3):160-169. PubMed ID: 30550403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries.
    Behr C; Koffijberg H; IJzerman M; Kauczor HU; Revel MP; Silva M; von Stackelberg O; van Til J; Vliegenthart R
    Eur Radiol; 2024 Jul; 34(7):4448-4456. PubMed ID: 38060003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study.
    Du Y; Li Q; Sidorenkov G; Vonder M; Cai J; de Bock GH; Guan Y; Xia Y; Zhou X; Zhang D; Rook M; Vliegenthart R; Heuvelmans MA; Dorrius MD; van Ooijen PMA; Groen HJM; van der Harst P; Xiao Y; Ye Z; Xie X; Wang W; Oudkerk M; Fan L; Liu S
    Acad Radiol; 2021 Jan; 28(1):36-45. PubMed ID: 32151538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial.
    Sørensen L; Nielsen M; Petersen J; Pedersen JH; Dirksen A; de Bruijne M
    AJR Am J Roentgenol; 2020 Jun; 214(6):1269-1279. PubMed ID: 32255690
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants.
    de Jong WU; de Jong PA; Vliegenthart R; Isgum I; Lammers JW; Oudkerk M; van der Aalst C; de Koning HJ; Mohamed Hoesein FA
    J Bone Miner Res; 2014 Oct; 29(10):2224-9. PubMed ID: 24715549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic.
    Young RP; Hopkins R
    Expert Rev Respir Med; 2019 Aug; 13(8):699-707. PubMed ID: 31274043
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of high-resolution CT imaging data to lung cancer drug development: measuring progress: workshop IX.
    Mulshine JL; Avila R; Yankelevitz D; Baer TM; Estepar RS; Fenton L; Aldige CR
    J Thorac Oncol; 2013 Nov; 8(11):1352-5. PubMed ID: 24128711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation Exposure.
    Mulshine JL
    Am J Public Health; 2018 Oct; 108(10):1294-1295. PubMed ID: 30207781
    [No Abstract]   [Full Text] [Related]  

  • 18. CT Imaging and Comorbidities in COPD: Beyond Lung Cancer Screening.
    Singhvi D; Bon J
    Chest; 2021 Jan; 159(1):147-153. PubMed ID: 32835707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating other diseases with computed tomographic screening for lung cancer.
    Wittig G
    JAMA; 2013 Feb; 309(7):656. PubMed ID: 23423405
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating other diseases with computed tomographic screening for lung cancer--reply.
    Mets OM; de Jong PA; Prokop M
    JAMA; 2013 Feb; 309(7):656-7. PubMed ID: 23423406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.